We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
On 8 May 2018, Democratic Republic of Congo (DRC) declared an outbreak of Ebola in the northeast.
The new outbreak, in DRC's northeastern Equateur province, is the country's ninth Ebola outbreak in 40 years. It is also the second epidemic since the end of the outbreak in West Africa in 2016. Previous outbreaks in DRC have been in remote, isolated areas, with few people infected and contained relatively quickly. In this new outbreak, cases have been confirmed in the busy port city of Mbandaka, which has more than a million inhabitants, worrying authorities about its spread in an urban area.
MSF response to second Ebola outbreak in DRC since 2016
Project Update23 May 2018
DRC 2018 Ebola outbreak
Ninth Ebola outbreak in 40 years hits urban area
Project Update17 May 2018
Democratic Republic of Congo
In DRC, MSF runs some of its largest medical relief operations, working in 20 of 26 provinces, responding to diseases outbreaks, conflict and displacement, and tackling health problems such as HIV/AIDs.
Key figures 2017: 1.7 million consultations; expenditure 103 million euros; 2881 field staff
patients treated for malaria
patients admitted to hospital
Ebola and Marburg
Ebola and Marburg haemorrhagic fevers are rare but deadly. Outbreaks can kill 25 to 90 per cent of those infected, spreading fear and panic. No cure exists and treatment is mainly symptomatic.
Epidemics and pandemics
Millions of people still die each year from infectious diseases that are preventable or can be treated.